Rezolute Total Assets 2011-2025 | RZLT

Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.

Main categories of assets
Current assets (used within one year):

Cash and cash equivalents
Accounts receivable (amounts owed by customers)
Inventory of goods, raw materials, and supplies
Short-term investments

Non-current assets (used for more than one year):

Fixed assets (buildings, machinery, equipment)
Intangible assets (brands, patents, software)
Long-term investments
Goodwill (reputational value from mergers)

Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.

Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.

Annual Total Assets Rezolute

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
175 M	133 M	124 M	152 M	42.6 M	11 M	12.3 M	2.5 M	10.6 M	10.9 M	11.3 M	7.4 M	1.1 M	5.13 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
175 M	5.13 K	49.6 M

Quarterly Total Assets Rezolute

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
159 M	175 M	94.7 M	112 M	123 M	133 M	87.7 M	102 M	113 M	124 M	134 M	150 M	156 M	152 M	69.6 M	83.4 M	38.8 M	42.6 M	42.6 M	38.9 M	7.41 M	11 M	11 M	20.6 M	26.6 M	12.3 M	12.3 M	456 K	1.07 M	2.5 M	2.5 M	6.32 M	9.8 M	10.6 M	10.6 M	9.94 M	10.1 M	10.9 M	10.9 M	8.53 M	9.17 M	11.3 M	11.3 M	10.7 M	6.27 M	7.4 M	7.4 M	2.15 M	864 K	1.1 M	1.1 M	-	480	1.07 M	8.89 K	566 K	23.5 K	15.8 K	23.5 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
175 M	480	41.3 M

Total Assets of other stocks in the Biotechnology industry

Issuer	Total Assets	Price	% 24h	Market Cap	Country
AbbVie ABBV	135 B	$ 223.01	-0.99 %	$ 395 B	USA
ARCA biopharma ABIO	396 M	-	1052.0 %	$ 415 M	USA
Arbutus Biopharma Corporation ABUS	144 M	$ 4.68	1.85 %	$ 777 M	Canada
Aclaris Therapeutics ACRS	220 M	$ 3.38	3.21 %	$ 261 M	USA
Acasti Pharma ACST	72 M	-	4.01 %	$ 150 M	Canada
Adaptimmune Therapeutics plc ADAP	283 M	-	-15.15 %	$ 60.3 M	Britain
Aeglea BioTherapeutics AGLE	608 M	-	-	$ 1.01 B	USA
Ascendis Pharma A/S ASND	1.18 B	$ 212.3	5.5 %	$ 5 B	Danmark
Alexion Pharmaceuticals, Inc. ALXN	18.1 B	-	-	$ 40.3 B	USA
BioVie BIVI	21.6 M	$ 1.54	-2.53 %	$ 2.28 M	USA
Albireo Pharma ALBO	302 M	-	-0.23 %	$ 916 M	USA
Aptorum Group Limited APM	16.1 M	$ 1.33	-1.48 %	$ 7.25 M	China
Alpine Immune Sciences ALPN	287 M	-	-	$ 2.17 B	USA
Alterity Therapeutics Limited ATHE	41.4 M	$ 3.4	1.49 %	$ 8.18 B	Australia
EyeGate Pharmaceuticals, Inc. EYEG	15.2 M	-	-1.52 %	$ 24.7 M	USA
AstraZeneca PLC AZN	104 B	$ 90.34	-1.28 %	$ 96.9 B	Britain
Amphastar Pharmaceuticals AMPH	1.58 B	$ 25.76	0.19 %	$ 1.25 B	USA
Anika Therapeutics ANIK	271 M	$ 9.53	-1.19 %	$ 140 M	USA
Aytu BioScience AYTU	124 M	$ 2.33	2.3 %	$ 14.6 M	USA
Arena Pharmaceuticals ARNA	785 M	-	-6.81 %	$ 3.04 B	USA
Avenue Therapeutics ATXI	2.67 M	-	-52.27 %	$ 4.45 M	USA
Институт стволовых клеток человека ISKJ	1.51 B	-	-	-	Russia
Axon Enterprise AXON	4.47 B	$ 586.28	3.15 %	$ 44.4 B	USA
Biogen BIIB	28 B	$ 173.03	-2.55 %	$ 25.2 B	USA
Can-Fite BioPharma Ltd. CANF	9.12 M	$ 0.29	-5.01 %	$ 631 M	Israel
Brickell Biotech BBI	11.6 M	-	-5.38 %	$ 6.06 M	USA
Benitec Biopharma BNTC	99.6 M	$ 12.91	0.78 %	$ 531 M	USA
BioNTech SE BNTX	22.5 B	$ 95.9	0.17 %	$ 27.2 B	Germany
Biohaven Pharmaceutical Holding Company Ltd. BHVN	1.08 B	$ 11.55	8.86 %	$ 747 M	USA
Enochian Biosciences ENOB	8.23 M	-	-	$ 40.5 M	USA
Catalyst Biosciences CBIO	117 M	$ 15.32	5.73 %	$ 1.01 B	USA
Acer Therapeutics ACER	11.6 M	-	2.71 %	$ 14 M	USA
BeiGene, Ltd. BGNE	5.92 B	-	0.49 %	$ 251 B	Cayman-islands
Cerus Corporation CERS	201 M	$ 2.14	13.23 %	$ 395 M	USA
Acorda Therapeutics ACOR	109 M	-	-24.86 %	$ 820 K	USA
Applied Molecular Transport AMTI	107 M	-	-	$ 10.1 M	USA
Burford Capital Limited BUR	3.11 B	$ 9.15	-0.44 %	$ 1.47 B	Britain
Berkeley Lights BLI	226 M	-	-7.31 %	$ 87 M	USA
bluebird bio BLUE	619 M	-	-	$ 546 M	USA
Cellectar Biosciences CLRB	12.1 M	$ 3.81	-5.35 %	$ 46.6 M	USA
Bristol-Myers Squibb Company BMY	92.6 B	$ 51.05	-0.32 %	$ 103 B	USA
Abeona Therapeutics ABEO	64 M	$ 5.5	0.46 %	$ 118 M	USA
ADiTx Therapeutics ADTX	32.1 M	$ 2.36	-7.29 %	$ 31.1 K	USA
BioXcel Therapeutics BTAI	38.3 M	$ 2.1	-4.34 %	$ 5.32 M	USA
Coherus BioSciences CHRS	630 M	$ 1.42	6.77 %	$ 134 M	USA
BioLineRx Ltd. BLRX	38.9 M	$ 3.22	-2.72 %	$ 908 M	Israel
Celldex Therapeutics CLDX	792 M	$ 28.33	0.5 %	$ 1.82 M	USA
Advaxis ADXS	16.6 M	-	-9.65 %	$ 45.9 M	USA
Baudax Bio BXRX	10 M	-	0.59 %	$ 63 K	USA
Завод ДИОД DIOD	1.4 B	-	-	-	Russia